Press Release – New York, NY – February 2, 2021 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten offering of 10,000,000 shares of the common stock of Avinger, Inc. (NASDAQ: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), at a price of $1.44 per share. The gross proceeds of the offering were approximately $14.4 million, prior to deducting underwriting discounts and commissions and estimated offering expenses.
The shares were offered pursuant to a shelf registration statement previously filed with and declared effective by the SEC.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin M. Ocasio, and Jay Yamamoto, and associate Matthew Siracusa.
- Sichenzia Ross Ference Carmel LLP Represents BriaCell Therapeutics in $15 Million Public Offering - July 16, 2025
- Sichenzia Ross Ference Carmel LLP Represents 60 Degrees Pharmaceuticals in Public Offering of Up to $10 Million - July 15, 2025
- Sichenzia Ross Ference Carmel LLP Represents Viewbix in $4.5 Million Private Placement - July 15, 2025